These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 14706048)

  • 1. Diabetic renal disease: from recent studies to improved clinical practice.
    Mogensen CE; Cooper ME
    Diabet Med; 2004 Jan; 21(1):4-17. PubMed ID: 14706048
    [No Abstract]   [Full Text] [Related]  

  • 2. Optimal dosing of renin-angiotensin-aldosterone system blockers for renal protection: a solved issue?
    Laverman GD; Bakker SJ; Navis GJ
    Diabetologia; 2009 Jun; 52(6):1217-8. PubMed ID: 19294362
    [No Abstract]   [Full Text] [Related]  

  • 3. [Antihypertensive drug trials also reveal renoprotective effects].
    Kiss I
    Orv Hetil; 2013 May; 154(19):753-6. PubMed ID: 23649640
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dual blockade of the renin-angiotensin system in diabetic nephropathy: a randomized double-blind crossover study.
    Rossing K; Christensen PK; Jensen BR; Parving HH
    Diabetes Care; 2002 Jan; 25(1):95-100. PubMed ID: 11772908
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Control of arterial pressure in diabetic nephropathy].
    Luño J; García de Vinuesa S
    Nefrologia; 2001; 21(3):240-5. PubMed ID: 11471304
    [No Abstract]   [Full Text] [Related]  

  • 6. Antihypertensive therapy in patients with diabetic nephropathy.
    Mehler PS; Schrier RW
    Kidney Blood Press Res; 1997; 20(2):74-81. PubMed ID: 9293422
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Blood pressure, hypertension, RAAS blockade, and drug therapy in diabetic kidney disease.
    Yamout H; Lazich I; Bakris GL
    Adv Chronic Kidney Dis; 2014 May; 21(3):281-6. PubMed ID: 24780456
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of angiotensin receptor blockers in diabetic nephropathy.
    Sharma AM; Weir MR
    Postgrad Med; 2011 May; 123(3):109-21. PubMed ID: 21566421
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The effect of angiotensin-converting enzyme inhibitors on the progression of chronic renal failure].
    Bernadet-Monrozies P; Rostaing L; Kamar N; Durand D
    Presse Med; 2002 Nov; 31(36):1714-20. PubMed ID: 12467154
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Present and future in the treatment of diabetic kidney disease.
    Quiroga B; Arroyo D; de Arriba G
    J Diabetes Res; 2015; 2015():801348. PubMed ID: 25945357
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative effects of indapamide and captopril on blood pressure and albumin excretion rate in diabetic microalbuminuria.
    Donnelly R; Molyneaux LM; Willey KA; Yue DK
    Am J Cardiol; 1996 Feb; 77(6):26B-30B. PubMed ID: 8848991
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Protective effect of antihypertensive agents on renal insufficiency (REIN, RENAAL, IDNT, AASK, etc)].
    Tsuchida H; Kimura K
    Nihon Rinsho; 2004 Mar; 62 Suppl 3():617-22. PubMed ID: 15171445
    [No Abstract]   [Full Text] [Related]  

  • 13. [Pharmacological prevention and treatment of diabetic nephropathy].
    Aitio ML
    Duodecim; 1993; 109(6):503-11. PubMed ID: 8062718
    [No Abstract]   [Full Text] [Related]  

  • 14. Angiotensin II receptor blockade in diabetic nephropathy.
    Andersen S
    Dan Med Bull; 2004 Aug; 51(3):274-94. PubMed ID: 16009059
    [No Abstract]   [Full Text] [Related]  

  • 15. Dual blockade of the renin-angiotensin system in diabetic nephropathy.
    Ravid M
    Diabetes Care; 2009 Nov; 32 Suppl 2(Suppl 2):S410-3. PubMed ID: 19875590
    [No Abstract]   [Full Text] [Related]  

  • 16. [Renin-angiotensin system in diabetic nephropathy].
    Luño J
    Nefrologia; 2005; 25 Suppl 2():73-81. PubMed ID: 16050407
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Renoprotection by blockade of the renin-angiotensin-aldosterone system in diabetic and non-diabetic chronic kidney disease. Specific involvement of intra-renal angiotensin-converting enzyme activity in therapy resistance?
    Vogt L; Kocks MJ; Laverman GD; Navis G
    Minerva Med; 2004 Oct; 95(5):395-409. PubMed ID: 15467515
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Renin-angiotensin-aldosterone system blockade and urinary albumin excretion in community-based patients with Type 2 diabetes: the Fremantle Diabetes Study.
    Fegan PG; Davis WA; Kamber N; Sivakumar S; Beilby J; Davis TM
    Diabet Med; 2011 Jul; 28(7):849-55. PubMed ID: 21231957
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic effects of angiotensin II inhibition or blockade on the progression of chronic renal disease.
    Cantarovich F; Rangoonwala B
    Int J Clin Pract; 2003 Nov; 57(9):801-22. PubMed ID: 14686572
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The renin-angiotensin system and diabetic nephropathy.
    Gurley SB; Coffman TM
    Semin Nephrol; 2007 Mar; 27(2):144-52. PubMed ID: 17418683
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.